JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$590,624 | -$767,996 | -$846,135 | -$702,328 |
| Dep. & Amort. | $89,663 | $99,834 | $81,366 | $46,327 |
| Deferred Tax | $0 | $0 | -$68,440 | -$60,586 |
| Stock-Based Comp. | $37,309 | $34,965 | $82,502 | $89,370 |
| Change in WC | -$29,814 | $3,188 | -$14,062 | $49,785 |
| Other Non-Cash | $160,023 | $231,591 | $228,047 | $16,234 |
| Operating Cash Flow | -$333,443 | -$398,418 | -$536,722 | -$561,198 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,279 | -$12,409 | -$76,874 | -$73,087 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$23,552 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$10,146 | $22,313 | -$23,657 | -$64,043 |
| Investing Cash Flow | -$15,425 | $9,904 | -$124,083 | -$137,130 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $118,571 | $27,700 | $134,800 | -$13,020 |
| Stock Issued | $403 | $27 | $94 | $697 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$28,484 | -$27,452 | -$22,540 | -$18,298 |
| Financing Cash Flow | $90,490 | $275 | $112,354 | -$30,621 |
| Forex Effect | $9,844 | $10,812 | $97,388 | -$67,250 |
| Net Chg. in Cash | -$248,534 | -$377,427 | -$451,063 | -$796,199 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,005,909 | $1,383,336 | $1,834,399 | $2,630,598 |
| End Cash | $757,375 | $1,005,909 | $1,383,336 | $1,834,399 |
| Free Cash Flow | -$348,868 | -$412,998 | -$613,596 | -$634,285 |